Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phoenix: Somatropin and Leuprorelin in Pubertal Children with Idiopathic Short Stature
NCT00355030Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2006
- Primary completion
- Jul 2015
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of leuprolide in Idiopathic Short Stature (ISS), sponsored by Eli Lilly and Company. Started Jun 2006; status: completed.
02
Drugs
leuprolide
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on NCT00355030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00355030.